Alternative dosing regimens of GLP-1 receptor agonists may reduce costs and maintain weight loss efficacy
Cengiz A, Wu CC, Lawley SD
Diabetes Obes Metab. Pub. online 14 Feb 2025.
Leggi
Cengiz A, Wu CC, Lawley SD
Diabetes Obes Metab. Pub. online 14 Feb 2025.
Leggi
Rickels MR, Ballou CM, Foster NC, et al.
Diabetes Care. 2025:dc241915.
Leggi
Kornum DS, Krogh K, Keller J, et al.
Diabetologia. Pub. online 11 Feb 2025.
Leggi
Carino M, New RH, Nguyen J, et al.
Diabetes Res Clin Pract. 2025:112045.
Leggi
De Meulemeester J, Keymeulen B, De Block C, et al.
Diabetologia. Pub. online 11 Feb 2025.
Leggi
Bellemare M, Bourcier L, Iglesies-Grau J, et al.
Diabetes Obes Metab. Pub. online 10 Feb 2025.
Leggi
Aggarwal R, Bhatt DL, Szarek M, et al.
Lancet Diabetes Endocrinol. Pub. online 13 Feb 2025.
Leggi
Ehrmann D, Krause-Steinrauf H, Uschner D, et al.
Diabetologia. Pub. online 14 Feb 2025.
Leggi
13/02/2025
Leggi
O’Donnell HK, Simmons KM, Gitelman SE, et al.
Diabetes Obes Metab. Pub. online 13 Feb 2025.
Leggi